Evidence map›Paper›PMID 31365583›Full record

ArticlePloS one2019

Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.

Beena Elizabeth Thomas, Kannan Thiruvengadam, Rani S, Dileep Kadam, Senthanro Ovung, Shrutha Sivakumar, Shri Vijay Bala Yogendra Shivakumar, Mandar Paradkar, Nikhil Gupte, Nishi Suryavanshi and 14 more

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Alcohol use disorder research in India: An update.Indian journal of psychiatry · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Beena Elizabeth ThomasNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Kannan ThiruvengadamNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Rani SNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Dileep KadamByramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Senthanro OvungNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Shrutha SivakumarNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Shri Vijay Bala Yogendra ShivakumarJohns Hopkins University-India Office, Pune, Maharashtra, India.
Mandar ParadkarByramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Nikhil GupteByramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Nishi SuryavanshiByramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
C K DollaNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Akshay N GupteJohns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Rewa KohliByramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.ORCID 0000-0001-7208-1282
Neeta PradhanByramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Gomathi Narayan SivaramakrishnanNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Sanjay GaikwadByramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Anju KagalByramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Kavitha DhanasekaranNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Andrea DelucaJohns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Jonathan E GolubJohns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Vidya MaveByramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Padmapriyadarshini ChandrasekaranNational Institute for Research in Tuberculosis, ICMR, Chennai, Tamil Nadu, India.
Amita GuptaJohns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
CTRIUMPH-RePORT India Study

Funding

The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)UM1AI069465 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Charles W. Flexner, Amita Gupta · 2012 to 2026
$34.1M
The Impact of Diabetes on TB treatment outcomesR01AI097494 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GOLUB, JONATHAN E. · 2013 to 2017
$3.0M
NIAID NIH HHS R01 AI097494NIAID NIH HHS UM1 AI069465
6 · The paper itself

Abstract

backgroundMore than 20% of tuberculosis (TB) disease worldwide may be attributable to smoking and alcohol abuse. India is the second largest consumer of tobacco products, a major consumer of alcohol particularly among males, and has the highest burden of TB globally. The impact of increasing tobacco dose, relevance of alcohol misuse and past versus current or never smoking status on TB treatment outcomes remain inadequately defined.

methodsWe conducted a multi-centric prospective cohort study of newly diagnosed adult pulmonary TB patients initiated on TB treatment and followed for a minimum of 6 months to assess the impact of smoking status with or without alcohol abuse on treatment outcomes. Smokers were defined as never smokers, past smokers or current smokers. Alcohol Use Disorder Identification Test (AUDIT) scores were used to assess alcohol misuse. The association between smoking status and treatment outcomes was assessed in univariate and multivariate random effects poisson regression models.

resultsOf 455 enrolled, 129 (28%) had a history of smoking with 94 (20%) current smokers and 35 (8%) past smokers. Unfavourable treatment outcomes were significantly higher among past and current smokers as compared to never smokers. Specifically, the risk of treatment failure was significantly higher among past smokers (aIRR = 2.66, 95% CI: 1.41-4.90, p = 0.002), recurrent TB among current smokers (aIRR = 2.94, 95% CI: 1.30-6.67, p = 0.010) and death among both past (2.63, 95% CI: 1.11-6.24, p = 0.028) and current (aIRR = 2.59, 95% CI: 1.29-5.18, p = 0.007) smokers. Furthermore, the combined effect of alcohol misuse and smoking on unfavorable treatment outcomes was significantly higher among past smokers (aIRR: 4.67, 95% CI: 2.17-10.02, p<0.001) and current smokers (aIRR: 3.58, 95% CI: 1.89-6.76, p<0.001).

conclusionPast and current smoking along with alcohol misuse have combined effects on increasing the risk of unfavourable TB treatment outcomes. Innovative interventions that can readily address both co-morbidities are urgently needed.

Indexed as

AdultAlcoholismAntitubercular AgentsFemaleHumansMaleMiddle AgedMycobacterium tuberculosisProspective StudiesRecurrenceSmokingSurvival RateTreatment OutcomeTuberculosisAntitubercular Agents

Identifiers

PMID31365583
PMCPMC6668833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.